Loading Events

Upcoming Events › Grant

Events Search and Views Navigation

Event Views Navigation

August 2022

Robert E. Leet and Clara Guthrie Patterson Trust Mentored Research Award: Clinical, Health Services and Policy Research

August 16

Sponsor: The Medical Foundation

Deadline:August 16, 2022 at 12:00 PM ET

Award: “Two-year awards of $200,000 ($100,000 per year) will be awarded to Applicants working in Connecticut, New Jersey, and Rhode Island.

Research Focus: The program supports projects and studies spanning a broad range of disciplines involving clinical research, including patient-oriented research conducted with human subjects (or on material of human origin), epidemiological and behavioral studies, outcomes research and health services research. Investigators interested in population health research that seeks to address social determinants of health and/or health inequities as a lever for improving human, health are encouraged to apply. Proposals utilizing animal studies or those with a predominant focus on fundamental aspects of phenomena without direct clinical application are ineligible.”

Find out more »

Civic Engagement Microgrants

August 24

Sponsor: Research!America (in collaboration with the Rita Allen Foundation)

Due Date: August 24, 2022

Award: Now in its fifth year, the Microgrant program provides early career scientists with hands-on opportunities to develop skills in communication and program planning and a working knowledge of policy and government to become articulate spokespersons for science and research to public officials and members of their local communities.

Find out more »

September 2022

AES Research and Training Workshops for Clinicians

September 1

Sponsor: American Epilepsy Society
Due Date: September 2022
Award: “AES Research and Training Fellowships for Clinicians provide mentored support for clinical fellows or recently appointed clinical faculty who intend to pursue a career in epilepsy research. Proposals are welcomed across the spectrum of basic, translational, and clinical research.

The fellowship award provides up to $50,000 for one year, of which $1,000 is intended as travel support to attend the AES Annual Meeting. The award also includes one-year AES membership and complimentary registration to the AES Annual Meeting.”

Find out more »

Career Awards at the Scientific Interface

September 1

SponsorBurroughs Wellcome Fund
Pre-proposal Deadline: September 1, 2022
Invited Proposal Deadline: January 6, 2023
Award: BWF’s Career Awards at the Scientific Interface (CASI) provide $500,000 over five years to bridge advanced postdoctoral training and the first three years of faculty service. These awards are open to U.S. and Canadian citizens, permanent residents, and temporary residents.

Find out more »

AES Postdoctoral Research Fellowships

September 1

Sponsor:American Epilepsy Society

Deadline: September 2022

Award: “AES Postdoctoral Research Fellowships support postdoctoral trainees conducting research into the causes, treatment, and consequences of epilepsy under the guidance of a mentor with expertise in epilepsy research. Proposals are welcomed across the spectrum of basic, translational, and clinical epilepsy research.

The fellowship award offers up to $50,000 for stipend and travel support to the AES Annual Meeting for one year, as well as a one-year AES membership. The number of awards granted each year is contingent upon available funds.”

Find out more »

Cycle 1: Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R43/R44)

September 5

Sponsor: National Institutes of Health
Due Date: September 5, 2022 by 5 pm local time of applicant
Award: This funding opportunity announcement (FOA) encourages applications from small business concerns for Small Business Innovation Research (SBIR) projects that propose innovative research and development of technology for cryogenic or other long-term preservation and revival of Drosophila and zebrafish genetic stocks. The proposed technologies should be reliable, reproducible and cost effective for the long-term preservation and revival of wild type and laboratory created genetic stocks.

Find out more »

Cycle 1: Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R41/R42)

September 5

Sponsor: National Institutes of Health
Due Date: September 5, 2022 by 5 pm local time of applicant
Award: This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Technology Transfer (STTR) projects that propose innovative research and development of technology, including reagents and high throughput equipment, to support different aspects of the creation, detection, identification and characterization of zebrafish models of human disease and preservation of genetic stocks. Money, property, or both to an eligible entity to carry out an approved project or activity. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)

September 5

Sponsor: National Institute of Neurological Disorders and Stroke
Due Date: September 5, 2022
Award: This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS mission.  An identified candidate, which has sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required for entry to the CREATE Bio Development Track. The FOA supports Investigational New Drug (IND)-enabling studies for the candidate and early-phase clinical trials. At the end of the funding period, a successful project should have an IND application submitted to the U.S. Food and Drug Administration (FDA), at a minimum.  The program supports early-phase clinical trials, although these are not required.    

Find out more »

Cycle 2: NIH Small Business Grant

September 5

DUE DATE: September 5, 2022

Small Business Innovation Research (SBIR): These programs congressionally require eligible governmental agencies to set aside a percentage of their extramural budget so that domestic small businesses can engage in R&D that has a strong potential for technology commercialization. Approx. $70,000,000 for SBIR Phase I.

Small Business Technology Transfer (STTR): These programs congressionally require eligible governmental agencies to set aside a percentage of their extramural budget so that domestic small businesses can engage in R&D that has a strong potential for technology commercialization. Approx. $15,000,000 for STIR Phase I.

Find out more »

Arnold O. Beckman Postdoctoral Fellowship

September 6

Sponsor: Arnold and Mabel Beckman Foundation
Due Date: September 6, 2022
Award: Fellows receive an annual salary of $54,000 and a $25,000 research budget that can be spent on research activities such as supplies, equipment, and conference and workshop travel.

Find out more »

Cycle 4: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

September 9

Sponsor: National Institutes of Health (multiple Institutes)
LOI Due Date: July 10, 2017
Application Due Date: August 9, 2022
Award: Actual needs; applicants should rarely exceed up to $500,000 total cost per year for Phase I and up to $1,500,000 total cost per year for the Phase II.

Find out more »

Transatlantic Networks of Excellence Program

September 13

Sponsor: Fondation Leducq

Deadline:
LOI: September 13, 2022
Full Application Deadline: February 14, 2023

Award:
The Leducq Foundation Transatlantic Networks of Excellence Program provides $7,000,000 over five years to teams of researchers working collaboratively in the areas of cardiovascular and neurovascular disease.

Find out more »

Cycle 3: The Midlife in the United States Study (U19)

September 25

Sponsor: National Institutes of Health
Due Date: September 25, 2022 by 5 pm local time of applicant organization
Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

Find out more »

Cycle 3: Ruth L. Kirschstein National Research Service Awards (T Series)

September 25

Sponsor: National Institutes of Health
Due Date: September 25, 2022
Award: The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the nation’s biomedical, behavioral, and clinical research needs. NRSA fellowships support the training of pre- and postdoctoral scientists, dual-degree investigators, and senior researchers.

Find out more »

Cycle 3: Alzheimer’s Drug Discovery Foundation

September 30

Cycle 3

  • Letter of Intent Deadline: September 30, 2022
  • Full Proposal Deadline: December 2, 2022

Drug Discovery Program
Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding can range from $150,000-$600,000 for a preclinical project.
Program to Accelerate Clinical Trials (PACT)
The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer’s disease and related dementias. The average award is up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered.
Biomarkers Development
This RFP seeks to support the development of CSF and neuroimaging biomarkers for multiple contexts of use One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of research.
Prevention Beyond the Pipeline
The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Awards range between $50,000-$100,000 for epidemiological analyses based on scope of research, and can reach up to $3 million for clinical trials based on stage and scope of research.

Find out more »

Cycle 3: Biomarkers Development

September 30

Sponsor: Alzheimer’s Drug Discovery Foundation

Deadlines:
Letter of Intent:
September 30, 2022

Invited Full Proposal:
December 2, 2022

Award:
The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Award Amount:
Up to $600,000 based on stage and scope of research.

Find out more »

Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)

September 30

Sponsor: NIH

Due Date:
LOA – 30 days prior to application due date
Application due date – September 30, 2022 and August 15, 2024

Award: Funding Opportunity RFA-OD-22-014 from the NIH Guide for Grants and Contracts. The ORWH and participating organizations and institutes seek applications for Specialized Centers of Research Excellence (SCORE) on Sex Differences. The Centers of Excellence will support interdisciplinary approaches to advance translational research on sex differences. Each SCORE institution should develop a research agenda bridging basic and clinical research underlying a health issue that is pertinent to improving the health of women.

Find out more »

October 2022

Gairdner International Awards

October 1

Sponsor: Gairdner Foundation

Nomination Due Date: October 1, 2022

Award: Seven awards of $100,000 Candadian. The Canada Gairdner International Award recognizes outstanding researchers whose unique scientific contributions have increased the understanding of human biology and disease and contributed to the relief of human suffering. The Gairdner Foundation invites the scientific community to nominate qualified researchers for this Award. Nominations in the field of translational research are welcome. The award is intended for seminal bodies of work, not cumulative lifetime achievement.

Find out more »

Cycle 3: Whitehall Foundation Grants-in-Aids

October 1

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: October 1, 2022
Application Due Date: February 15, 2022
Award: The Grants-in-Aid program is designed for researchers at the assistant professor level who experience difficulty in competing for research funds because they have not yet become firmly established. Grants-in-Aid can also be made to senior scientists. All applications will be judged on the scientific merit and innovative aspects of the proposal, as well as on past performance and evidence of the applicant’s continued productivity. Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

Find out more »

Cycle 3: Whitehall Foundation Research Grants

October 1

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: October 1, 2022
Application Due Date: February 15, 2022
Award: Research grants are available to established scientists of all ages working at accredited institutions in the United States. Applications will be judged on the scientific merit and the innovative aspects of the proposal as well as on the competence of the applicant. Research grants of up to three years will be provided. A renewal grant with a maximum of two years is possible, but it will be awarded on a competitive basis. Research grants will not be awarded to investigators who have already received, or expect to receive, substantial support from other sources, even if it is for an unrelated purpose. Research grants are normally $75,000 per year.

Find out more »
+ Export Events